Prof. Philip
Lazarovici, PhD, a Professor of Pharmacology who holds the Jacob Gitlin Chair
in Physiology, is a member of the Institute for Drug Research of the School of
Pharmacy, Faculty of Medicine at the Hebrew University of Jerusalem. An
acclaimed neuropharmacologist, Professor Lazarovici graduated in pharmacology
and toxicology at the Hebrew University, postgraduated in neurobiology at the
Weizmann Institute of Science, and conducted neurochemical and molecular
research at the National Institutes of Child Health and Human Development, NIH,
as a visiting scientist, which set the stage for his lifelong career in
neuropharmacology. His groundbreaking work provided the Israeli scientific
community with pharmacological knowledge towards the development of different
drugs and the elucidation of their mechanisms of action. Prof. Lazarovici is a
member of 15 international and national academic societies, has published more
than 250 scientific articles and reviews, and has edited six books in his field
of research. His research interests lie in the fields of neuropharmacology,
neurotoxicology, neurooncology, and neural engineering, focusing on toxins and
neurotrophins.
Research Keywords & Expertise
Drug Development
neurodegenerative dise...
disintegrins
Animal Venoms
neurotoxins
Nerve growth factors
Neurotoxicity and neur...
Neuropharmacology and ...
Preclinical pharmacolo...
In vitro and in vivo m...
Fingerprints
31%
Nerve growth factors
31%
In vitro and in vivo model systems
15%
disintegrins
8%
Drug Development
5%
neurodegenerative diseases
5%
neurotoxins
Short Biography
Prof. Philip
Lazarovici, PhD, a Professor of Pharmacology who holds the Jacob Gitlin Chair
in Physiology, is a member of the Institute for Drug Research of the School of
Pharmacy, Faculty of Medicine at the Hebrew University of Jerusalem. An
acclaimed neuropharmacologist, Professor Lazarovici graduated in pharmacology
and toxicology at the Hebrew University, postgraduated in neurobiology at the
Weizmann Institute of Science, and conducted neurochemical and molecular
research at the National Institutes of Child Health and Human Development, NIH,
as a visiting scientist, which set the stage for his lifelong career in
neuropharmacology. His groundbreaking work provided the Israeli scientific
community with pharmacological knowledge towards the development of different
drugs and the elucidation of their mechanisms of action. Prof. Lazarovici is a
member of 15 international and national academic societies, has published more
than 250 scientific articles and reviews, and has edited six books in his field
of research. His research interests lie in the fields of neuropharmacology,
neurotoxicology, neurooncology, and neural engineering, focusing on toxins and
neurotrophins.
Well done!
